Gland Pharma Ltd.(IN:GLAND)
₹3,229.80-19.45 (-0.60%)
IN:GLAND
Gland Pharma Ltd. financials statements
₹3,229.80
At close:-19.45 (-0.60%)
Want to see IN:GLAND full AI Analyst Report?
Gland Pharma Ltd. (GLAND) Ratios
1 Followers
Gland Pharma Ltd. Ratios
IN:GLAND's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:GLAND's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.68 | 4.33 | 4.04 | 9.46 | 10.05 |
| Quick Ratio | 3.60 | 3.26 | 2.84 | 6.75 | 7.94 |
| Cash Ratio | 2.09 | 1.63 | 0.26 | 2.62 | 0.54 |
| Solvency Ratio | 0.67 | 0.51 | 0.57 | 1.13 | 1.96 |
| Operating Cash Flow Ratio | 0.77 | 0.58 | 0.71 | 0.50 | 1.36 |
| Short-Term Operating Cash Flow Coverage | 7.10 | 4.78 | 4.67 | 649.94 | 7060.44 |
| Net Current Asset Value | ₹ 53.74B | ₹ 47.09B | ₹ 37.08B | ₹ 60.82B | ₹ 51.76B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.03 | 0.03 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.03 | 0.03 | 0.04 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.04 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.23 | 1.22 | 1.10 | 1.09 |
| Debt Service Coverage Ratio | 7.18 | 4.02 | 3.91 | 94.60 | 206.06 |
| Interest Coverage Ratio | 36.24 | 72.45 | 69.56 | 155.35 | 302.17 |
| Debt to Market Cap | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 19.23 | 20.50 | 24.18 | 0.72 | 0.61 |
| Net Debt to EBITDA | -1.60 | -1.82 | 0.01 | -1.85 | -0.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 30.05% | 56.16% | 54.92% | 48.70% | 48.89% |
| EBIT Margin | 23.29% | 15.53% | 17.15% | 24.40% | 31.81% |
| EBITDA Margin | 29.88% | 21.92% | 22.89% | 28.44% | 34.32% |
| Operating Profit Margin | 18.75% | 30.94% | 32.17% | 31.92% | 35.99% |
| Pretax Profit Margin | 22.77% | 18.92% | 19.99% | 29.10% | 36.78% |
| Net Profit Margin | 15.98% | 12.44% | 13.64% | 21.55% | 27.53% |
| Continuous Operations Profit Margin | 15.98% | 12.44% | 13.64% | 21.55% | 27.53% |
| Net Income Per EBT | 70.14% | 65.73% | 68.21% | 74.06% | 74.86% |
| EBT Per EBIT | 121.45% | 61.15% | 62.14% | 91.16% | 102.18% |
| Return on Assets (ROA) | 8.21% | 6.22% | 7.25% | 8.90% | 15.47% |
| Return on Equity (ROE) | 9.92% | 7.63% | 8.85% | 9.81% | 16.93% |
| Return on Capital Employed (ROCE) | 11.06% | 17.99% | 19.68% | 14.37% | 21.84% |
| Return on Invested Capital (ROIC) | 7.63% | 11.58% | 13.09% | 10.64% | 16.35% |
| Return on Tangible Assets | 8.48% | 6.43% | 7.49% | 8.91% | 15.49% |
| Earnings Yield | 3.68% | 2.73% | 2.59% | 3.74% | 2.25% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.40 | 3.70 | 3.44 | 3.50 | 3.40 |
| Payables Turnover | 5.39 | 3.00 | 2.96 | 3.17 | 4.86 |
| Inventory Turnover | 2.58 | 1.46 | 1.52 | 0.94 | 1.83 |
| Fixed Asset Turnover | 1.45 | 1.42 | 1.46 | 2.09 | 2.55 |
| Asset Turnover | 0.51 | 0.50 | 0.53 | 0.41 | 0.56 |
| Working Capital Turnover Ratio | 1.15 | 1.19 | 1.09 | 0.63 | 0.89 |
| Cash Conversion Cycle | 181.19 | 226.76 | 222.48 | 377.34 | 231.57 |
| Days of Sales Outstanding | 107.35 | 98.55 | 106.20 | 104.32 | 107.22 |
| Days of Inventory Outstanding | 141.50 | 249.83 | 239.58 | 388.30 | 199.45 |
| Days of Payables Outstanding | 67.66 | 121.62 | 123.29 | 115.29 | 75.10 |
| Operating Cycle | 248.86 | 348.38 | 345.78 | 492.63 | 306.68 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 74.73 | 55.52 | 60.51 | 22.10 | 48.06 |
| Free Cash Flow Per Share | 44.94 | 32.18 | 36.84 | 8.55 | 16.33 |
| Dividend Paid and CapEx Coverage Ratio | 1.56 | 1.28 | 2.56 | 1.63 | 1.51 |
| Capital Expenditure Coverage Ratio | 2.51 | 2.38 | 2.56 | 1.63 | 1.51 |
| Operating Cash Flow Coverage Ratio | 4.34 | 2.92 | 2.68 | 81.74 | 166.72 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.16 | 0.18 | 0.10 | 0.18 |
| Free Cash Flow Yield | 2.65% | 2.07% | 2.03% | 0.67% | 0.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 27.20 | 36.64 | 38.68 | 26.74 | 44.44 |
| Price-to-Sales (P/S) Ratio | 4.35 | 4.56 | 5.27 | 5.76 | 12.24 |
| Price-to-Book (P/B) Ratio | 2.70 | 2.80 | 3.43 | 2.62 | 7.52 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 37.74 | 48.27 | 49.24 | 148.28 | 200.44 |
| Price-to-Operating Cash Flow Ratio | 22.70 | 27.98 | 29.98 | 57.38 | 68.10 |
| Price-to-Earnings Growth (PEG) Ratio | 0.58 | -3.83 | -33.98 | -0.75 | 2.61 |
| Enterprise Value Multiple | 12.94 | 18.96 | 23.05 | 18.41 | 35.45 |
| Enterprise Value | 248.70B | 233.52B | 298.95B | 189.80B | 535.37B |
| EV to EBITDA | 12.94 | 18.96 | 23.05 | 18.41 | 35.45 |
| EV to Sales | 3.87 | 4.16 | 5.28 | 5.24 | 12.17 |
| EV to Free Cash Flow | 33.58 | 44.04 | 49.26 | 134.76 | 199.28 |
| EV to Operating Cash Flow | 20.20 | 25.53 | 29.99 | 52.15 | 67.70 |
| Tangible Book Value Per Share | 604.22 | 533.96 | 508.04 | 482.60 | 434.25 |
| Shareholders’ Equity Per Share | 628.65 | 555.45 | 529.56 | 483.30 | 435.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.30 | 0.34 | 0.32 | 0.26 | 0.25 |
| Revenue Per Share | 390.29 | 340.92 | 343.86 | 220.11 | 267.46 |
| Net Income Per Share | 62.35 | 42.40 | 46.89 | 47.43 | 73.64 |
| Tax Burden | 0.70 | 0.66 | 0.68 | 0.74 | 0.75 |
| Interest Burden | 0.98 | 1.22 | 1.17 | 1.19 | 1.16 |
| Research & Development to Revenue | 0.03 | 0.00 | 0.00 | 0.06 | 0.05 |
| SG&A to Revenue | 0.08 | 0.25 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.20 | 1.31 | 1.29 | 0.35 | 0.49 |
Currency in INR

